Doxorubicin Hydrochloride Liposome 00338-0080-01
- Manufacturer
- Baxter Healthcare Company
- Dosage Form
- Injection, Suspension, Liposomal
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 15, 2019
- Listing Expires
- December 31, 2026
- Application
- NDA050718
Need to source Doxorubicin Hydrochloride Liposome? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Doxorubicin Hydrochloride | 2 mg/mL |
Drug Class
Anthracycline Topoisomerase Inhibitor [EPC]Anthracyclines [CS]Topoisomerase Inhibitors [MoA]
Selected Package
00338-0080-01Selected1 VIAL, SINGLE-USE in 1 CARTON (0338-0080-01) / 10 mL in 1 VIAL, SINGLE-USE